Treatment of Chronic Hepatitis C Virus Infection in Dialysis Patients: An Update

  • Weclawiak H
  • Kamar N
  • Ould-Mohamed A
  • et al.
N/ACitations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Hepatitis C virus (HCV) infection is a blood-borne infection and its prevalence used to be elevated in hemodialysis (HD) patients. Its main mode of contamination relies on nosocomial transmission. HCV infection is frequently associated in HD patients with normal liver enzymes whereas liver histology can display some degree of HCV-related lesions. The assessment of HCV-related lesions, even in HD dialysis patients, can be done via noninvasive tests. After kidney transplantation, HCV-related lesions can worsen; however, in this setting antiviral treatment harbors the risk of acute rejection. Therefore, it is recommended to implement antiviral treatment while the patient is receiving dialysis therapy. In this setting, the rate of viral clearance is usually high. In case of sustained virological response, no relapse occurs after kidney transplantation, despite heavy immunosuppression.

Cite

CITATION STYLE

APA

Weclawiak, H., Kamar, N., Ould-Mohamed, A., Cardeau-Desangles, I., Izopet, J., & Rostaing, L. (2010). Treatment of Chronic Hepatitis C Virus Infection in Dialysis Patients: An Update. Hepatitis Research and Treatment, 2010, 1–6. https://doi.org/10.1155/2010/267412

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free